Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MIR.V Relative to the S&P 500

MIR.V Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the MedMira, Inc. (TSXV:MIR.V) seasonal charts above shows that a Buy Date of November 9 and a Sell Date of March 13 has resulted in a geometric average return of 6.94% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 25.77% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. Its products include HIV, Covid-19, Syphilis, Multiplex, Miriad, RVF Toolkit, and H.Pylori. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.

To download MIR.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MIR.V